AI in Drug Development: Beyond the Usual Playbook
Join us on December 9th from 5–8 PM ET for this invite-only evening of discussion and connection hosted by Nucleate and Sanofi's External Scientific Affairs team from Vaccines R&D.
We welcome founders, researchers, technical experts, and emerging leaders working (or aspiring to work) at the intersection of AI and life sciences.
AI in Drug Development: Beyond the Usual Playbook will bring together experts from pharma, biotech, and academia to explore how new AI tools are transforming discovery, development, and translational science. The conversation will focus on real-world applications—where AI is truly making a difference—and what collaboration between startups and established industry can achieve.
Our program features:
A panel discussion with leaders at the forefront of AI innovation in life sciences
Flash pitches from emerging startups and researchers using AI to accelerate discovery
A networking reception connecting attendees across pharma, biotech, and academia
Panelists include:
Chelsea Trengrove - CEO Neoclease (Generative-AI powered gene editing)
Colles Price - CEO TALOX
Vikram Agarwal - Head of mRNA Platform Design Data Science
Shameer Khader - Executive Director AI, Data Science, Bioinformatics, Genomics, Biometrics & Drug Discovery
Event Details:
Date: December 9, 2025
Time: 5:00–8:00 PM ET
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout, Browne Consulting
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta